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Abstract
Drosophila melanogaster responds to gram-negative bacterial challenges through the IMD pathway, a signal transduction
cassette that is driven by the coordinated activities of JNK, NF-kB and caspase modules. While many modifiers of NF-kB
activity were identified in cell culture and in vivo assays, the regulatory apparatus that determines JNK inputs into the IMD
pathway is relatively unexplored. In this manuscript, we present the first quantitative screen of the entire genome of
Drosophila for novel regulators of JNK activity in the IMD pathway. We identified a large number of gene products that
negatively or positively impact on JNK activation in the IMD pathway. In particular, we identified the Pvr receptor tyrosine
kinase as a potent inhibitor of JNK activation. In a series of in vivo and cell culture assays, we demonstrated that activation of
the IMD pathway drives JNK-dependent expression of the Pvr ligands, Pvf2 and Pvf3, which in turn act through the Pvr/ERK
MAP kinase pathway to attenuate the JNK and NF-kB arms of the IMD pathway. Our data illuminate a poorly understood
arm of a critical and evolutionarily conserved innate immune response. Furthermore, given the pleiotropic involvement of
JNK in eukaryotic cell biology, we believe that many of the novel regulators identified in this screen are of interest beyond
immune signaling.
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Introduction
The adaptive immune response is a recent evolutionary
acquisition by vertebrates. In contrast, the innate immune response
is highly conserved among metazoans and is the first line of defense
against invading pathogens [1]. Drosophila melanogaster is a powerful
model for the study of innate immune signaling events owing to the
high degree of evolutionary conservation of signal transduction
pathways [2]. For example, pioneering studies in Drosophila led to
the characterization of Toll as an essential element of invertebrate
immune armories, which prompted the search for and character-
ization of Toll homologs in humans [3,4]. The identification of the
mammalian Toll-like Receptor (TLR) family revolutionized the
study of innate immunity in humans and continues to have a
profound impact on our understanding of the complexities of
vertebrate responses to infectious microbes.
Characterization of a mutation in the immune deficiency (imd) gene
uncovered a distinct immune response to gram-negative bacterial
infections in Drosophila [5]. Imd is a death-domain containing
protein with similarity to the Receptor Interacting Protein (RIP) of
the mammalian Tumor Necrosis Factor (TNF) pathway [6].
Drosophila immunity to gram-negative bacteria requires an intact
IMD signaling pathway, which shares many other similarities with
the TNF pathway. Engagement of the IMD pathway requires
recognition of diaminopimelic acid-containing peptidoglycan
(PGN) by the PGN Receptor Protein (PGRP-LC) [7,8,9,10,11].
PGRP-LC coordinately activates the Drosophila c-Jun N-terminal
Kinase (dJNK) and the NF-kB transcription factor family member
Relish (Rel). The Rel arm of the IMD pathway is well
characterized thanks to a number of individual studies and
complementary genetic and cell culture RNA interference (RNAi)
screens. Essentially, Rel activation requires the activities of Imd,
the caspase-8 ortholog Dredd, dFADD, dTAB2, dIAP2 and the
MAP3 kinase dTAK1 [12,13,14,15,16,17,18,19,20,21].
Active dTAK1 drives the subsequent activation of the I-Kappa
Kinase(IKK)componentsKenny(Key)and Ird5 [22,23,24,25].Rel
is a p105 ortholog withan N-terminal Rel domainand a C-terminal
ankyrin repeat domain [26,27]. While the exact mechanism of Rel
activation requires clarification, a recent report identified two
distinct aspects to the generation of an active Rel [28]. Signal
transduction through the IMD pathway results in the endoproteo-
lytic cleavage of Rel of the N-terminal Rel domain from the
inhibitory ankrin repeat domain. At the same time, activation of
IKK activation drives the phosphorylation and transcriptional
activation of Rel. The Rel domain translocates to the nucleus and
initiates the transcription of a large number of genes, such as the
antimicrobial peptides (AMPs) attacin (att) and diptericin (dipt).
IMD pathway activation of dTAK1 also stimulates a kinase
cascade through the MAP2Ks dMAPKK4/7 that leads to dJNK
phosphorylation [29,30]. Phosphorylated dJNK typically activates
the nuclear translocation of the AP-1 transcription factor subunits
dJun and dFos, which initiate the transcription of dJNK depended
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IMD pathway [30]. pJNK protein levels are downregulated
through the combined activities of Rel and dJNK-responsive
transcripts such as the phosphatase Puckered [30,32,33]. Muta-
tions in djnk are lethal due to defective epithelial sheet sealing in
the dorsolateral axis of the developing embryo [34,35]. The
developmental requirement for dJNK and other components of
the dJNK arm of the IMD pathway has hampered the study of
dJNK signaling events in innate immune signaling. Thus, the
processes that regulate dJNK phosphorylation in the IMD
pathway are poorly understood and many of the mechanisms
that regulate dJNK signaling remain unknown.
Drosophila tissue culture cells provide an ideal environment to
study these events, as PGN-induced activation of the IMD
pathway induces a transient dJNK activation that is easily
quantified. To understand the regulation of PGN-induced dJNK
phosphorylation in the IMD pathway, we performed a high-
throughput, quantitative RNAi screen for modulators of dJNK
phosphorylation. To this end, we treated the embryonic
macrophage-like S2 cell line with 15,683 individual dsRNAs that
cover all annotated genes in the Drosophila genome. In contrast to
previous RNAi screens of the IMD pathway, our assay did not rely
on indirect reporter constructs. Instead, we used phospho-JNK
specific monoclonal antibodies in a quantitative plate-based assay
to directly quantify the impact of each dsRNA on the extent of
PGN-induced dJNK phosphorylation. In this manner, we
identified enhancers and suppressors of dJNK activation. As a
testament to the accuracy of this screen, we unambiguously
identified fifteen established IMD pathway components as
modifiers of dJNK activation. In addition, we identified numerous
novel regulators of dJNK activation. Given the involvement of
dJNK in cellular events as diverse as development, cell migration,
immune signaling and cell death, we believe that many of the
regulators identified in this screen will be of broad interest to the
study of metazoan cell biology.
We present a comprehensive analysis of a novel regulator of
dJNK in IMD pathway signaling – the PDGFR and VEGFR
receptor (Pvr) tyrosine kinase. Pvr is primarily known for its role in
the guidance of cellular movements [36,37,38,39,40,41,42]. We
uncover a novel inhibitory circuit in the IMD pathway, where
dJNK drives the expression of the Pvr ligands, Pvf2 and Pvf3,
which subsequently contribute to the downregulation of dJNK
activity via a Pvr/dERK signal transduction cassette. We also
demonstrate that Pvr attenuates the expression of Rel-responsive
transcripts by regulating the extent of Rel phosphorylation. We
confirm a regulatory role for Pvr in the IMD pathway with data
that loss of Pvr in adult Drosophila enhances the infection-induced
expression of att. These data indicate that the Pvr/dERK signal
transduction pathway constitutes a novel negative regulator of the
Drosophila IMD pathway.
Results
In-Cell Western (ICW) Assay for PGN-induced dJNK
Phosphorylation
Engagement of the IMD pathway leads to transient dJNK
phosphorylation; PGN-induced dJNK phosphorylation peaks at
5min and returns to basal levels by 60min in S2 cells (e.g.
Figure 1A, B). We developed a quantitative high-throughput
dsRNA screen to identify novel regulators of dJNK signaling in
the IMD pathway (Figure 1C). To this end, we treated Drosophila
S2 cells with a library of 15,683 dsRNAs that cover all annotated
genes in the Drosophila melanogaster genome and we monitored the
subsequent extent of PGN-induced dJNK phosphorylation by In
Cell Western (ICW) analysis. We used monoclonal antibodies
specific for phosphorylated JNK (P-JNK) and fluorescently
labeled secondary antibodies to directly visualize PGN-induced
dJNK phosphorylation. We simultaneously monitored filamen-
tous actin (f-actin) levels with fluorescently labeled phalloidin as a
c o n t r o lm e a s u r eo ft o t a lc e l ln u m b e r s .W et h e nq u a n t i f i e dt h e
ratio of P-JNK:f-actin for each well to determine the relative
extent of dJNK phosphorylation in each sample. To identify
genes that modulate the intensity and duration of dJNK
phosphorylation, we screened the entire genome at fifteen and
sixty minutes. We reasoned that depletion of gene products that
are required for optimal PGN-induced dJNK phosphorylation
will decrease dJNK phosphorylation at fifteen minutes and we
defined such gene products as enhancers of dJNK phosphory-
lation. Likewise, we reasoned that depletion of gene products
involved in dJNK dephosphorylation will increase the relative
intensity and/or duration of dJNK phosphorylation at fifteen
and/or sixty minutes and we defined such gene products as
suppressors of dJNK phosphorylation.
A representative 96-well plate from the screen is shown in
Figure 1D and the corresponding quantification of the P-JNK:f-
actin levels are shown in Figure 1E. Consistent with a previous
report [43], we identified Dredd as an enhancer of dJNK
phosphorylation. In addition, we identified the dJNK signaling
pathway element Cka as a suppressor of PGN-induced dJNK
phosphorylation. As expected, we identified Act79B as a regulator
of f-actin levels and the gene product Clk as essential for S2 cell
viability. To eliminate dsRNAs that negatively affected cell
viability or cell adherence, we excluded dsRNAs that greatly
reduced cell numbers as determined by an absence of f-actin and
P-JNK fluorescence from subsequent analyses. We then calculated
the P-JNK:f-actin z-score for all remaining wells to determine the
statistical significance of dsRNA-treatment on PGN-induced
dJNK phosphorylation and to allow for inter-plate comparisons.
By these criteria, we successfully identified Cka and Dredd as
statistically significant modifiers of dJNK phosphorylation with z-
scores of 7.70 and -3.48, respectively (Figure 1F). These data
Author Summary
Innate immunity is the sole immune response in the
overwhelming majority of multicellular organisms and
drives the sophisticated antigen-specific adaptive defenses
of vertebrates. Defective regulation of immune signal
transduction pathways has disastrous consequences for
affected individuals and can result in life-threatening
conditions that include cancer, autoimmune and neuro-
logical conditions. Thus, there is a major need to identify
the regulatory circuits that govern activation of critical
innate immune response pathways. The genetically
accessible model organism Drosophila melanogaster is an
ideal springboard for such studies, as core aspects of
innate immune pathways are evolutionarily conserved and
novel discoveries in Drosophila often inspire subsequent
developments in the characterization of biomedically
relevant mammalian pathways. Drosophila responses to
certain bacterial invaders proceed through the IMD
pathway, which contains partially overlapping signal
transduction JNK and NF-kB arms. While substantial efforts
have illuminated much of the NF-kB arm, there is a
considerable paucity of information on the regulation of
the JNK arm. We conducted a survey of the entire
Drosophila genome for novel regulators the Imd/dJNK
pathway. In this study, we uncovered a novel link between
the proliferative Pvr pathway and the IMD pathway.
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modifiers of PGN-induced dJNK phosphorylation in S2 cells.
Quantitative High-thoughput dsRNA Screen for
Regulators of PGN-induced dJNK Phosphorylation
We then measured the PGN-induced P-JNK:f-actin levels and
determined the z-score for all non-lethal dsRNA treatments. We
graphed all the z-scores from highest to lowest for both fifteen and
sixty minutes PGN-exposures (Figure 2A,B). dsRNA-mediated
depletion of enhancers or suppressors of PGN-dependent dJNK
phosphorylation resulted in reduced or elevated P-JNK z-scores,
respectively. The z-scores for all dsRNAs are available in Table
S1. We disregarded the P-JNK enhancers at sixty minutes PGN-
exposures because the level of PGN-induced dJNK phosphoryla-
tion was not sufficiently elevated over background P-JNK levels.
We identified Key as the strongest suppressor of dJNK
phosphorylation at both fifteen and sixty minutes with z-scores
of 9.05 and 9.23, respectively. Conversely, we identified dTAK1 as
the strongest enhancer of dJNK phosphorylation at fifteen minutes
PGN-exposure with a z-score of 25.7. As the Key/Rel axis of the
IMD pathway attenuates dJNK activation and dTAK1 is essential
for dJNK phosphorylation, these data are consistent with the
known roles of Key and dTAK1 in the IMD pathway. We
grouped all suppressors of dJNK phosphorylation with z-scores
above 2.58 at fifteen and sixty minutes and all enhancers of dJNK
phosphorylation with z-scores below 22.58 at fifteen minutes
according to their known biological functions (Figure 2C). We
identified many genes involved in innate immune signaling, in
addition to a large number of genes with previously uncharacter-
ized functions (Tables S2, S3, S4). As a testament to the saturation
Figure 1. Quantitative high-throughput RNAi screen for modifiers of dJNK phosphorylation. (A) Representative Western blot analysis of
S2 cell lysates treated with PGN for the indicated period. Lysates were probed with anti-P-JNK (top panel) and anti-actin (middle panel). To visualize
relative dJNK phosphorylation P-JNK (green) and actin (red) channels were false colored and merged (bottom panel). (B) Quantification of relative
dJNK phosphorylation in (A). dJNK phosphorylation levels were quantified and reported relative to actin levels for each of the indicated time points.
(C) Schematic representation of a quantitative RNAi screen for modifiers of PGN-induced dJNK phosphorylation. S2 cells were incubated with dsRNA
in 96 well plates prior to exposure to PGN. Cells were stained with an antibody specific for P-JNK and were counterstained with fluorescently labled
phalloidin to visualize filamentous actin (f-actin). JNK phosphorylation levels were quantified relative to f-actin levels. Loss of activators (enhancers) of
JNK phosphorylation decreases dJNK phosphorylation. In contrast, loss of inhibitory gene products (suppressors) increases dJNK phosphorylation.
Essential gene products are visible as wells with no P-JNK or f-actin staining. (D) Representative plate from screen. S2 cells incubated with 96 distinct
dsRNAs were treated with PGN for 15min. Cells were stained for P-JNK with monoclonal antibodies specific for P-JNK (left) and counterstained for f-
actin (center). To visualize relative P-JNK levels, P-JNK (green) and f-actin (red) channels were false colored and merged (right). (E) Quantification of
relative dJNK phosphorylation levels from panel D. Raw dJNK phosphorylation values were graphed against raw f-actin values. Red dashed lines
indicate + or 2 2.58 standard deviations from the median for both P-JNK and f-actin values. dsRNA targeting the established JNK modifiers Dredd and
Cka decrease or increase dJNK phosphorylation levels respectively with no effect on f-actin levels. (F) Statistical analysis of PGN-induced dJNK
phosphorylation relative to f-actin from panel E. P-JNK values were standardized to f-actin values for each of the 96 dsRNA treatments. The red
dashed lines represent z-score values of + or 2 2.58. dsRNA that targeted Cka and Dredd were identified as significant modifiers of PGN-induced
dJNK phosphorylation.
doi:10.1371/journal.ppat.1000655.g001
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modulators of PGN-induced dJNK phosphorylation with z-scores
above 1.96 or below 21.96 (Figure 2D). We note that in each case
the z-score is consistent with the established role of the fifteen
genes as either suppressors or enhancers of dJNK phosphorylation.
Validation of Pvr as a Suppressor of PGN-induced dJNK
Phosphorylation
To test the validity of the dsRNA screen, we selected a
representative cohort of three enhancers and eight suppressors of
PGN-induced dJNK phosphorylation for secondary analysis. We
monitored the effect of dsRNA treatment for all genes in the
cohort on dJNK phosphorylation relative to f-actin at zero, fifteen
and sixty minutes PGN-exposure. We compared the eleven
putative modifier dsRNAs to two dsRNAs (CG11318 and Toll)
that had no effect on dJNK phosphorylation in the primary screen.
Secondary dsRNA analysis was consistent with the screen results
as nine of the eleven dsRNAs significantly modified dJNK
phosphorylation relative to f-actin compared to control dsRNA
(Figure 3A). Even though we excluded actin modifiers from our
primary data analysis, we considered the possibility that a fraction
of the phenotypes observed may be indirectly caused by effects on
f-actin, as opposed to dJNK phosphorylation. To test this
hypothesis, we depleted each gene in the cohort and monitored
PGN-induced dJNK phosphorylation relative to total dJNK by
ICW (Figure 3B). We observed that the P-JNK:JNK analysis
essentially mirrored the P-JNK:f-actin analysis for each gene in the
cohort. Thus, we have confidence that our screen primarily
identified regulators of PGN-dependent dJNK phosphorylation.
To map relationships between the identified modulators of PGN-
induced dJNK phosphorylation, we mined known genetic and
physical interaction databases to develop an interaction network
for all hits in our primary screen. We restricted the interaction
network to direct physical or genetic interactions between genes
identified as modifiers of dJNK phosphorylation. Within this direct
interaction network we identified a branch with a high density of
interactions that spanned the IMD and the dJNK signaling
pathways (Figure 3C). The Drosophila PDGF/VEGF Receptor
(Pvr) homolog appeared as a major node within this branch.
To confirm Pvr as a suppressor of dJNK phosphorylation in the
IMD pathway, we depleted S2 cells of Pvr with two independ-
ent non-overlapping dsRNAs and monitored relative dJNK
Figure 2. Whole genome dsRNA screen for modifiers of PGN-
induced dJNK phosphorylation in the IMD pathway. (A,B)
Quantification of relative dJNK phosphorylation in S2 cells incubated
with 15,683 distinct dsRNAs prior to PGN exposure for 15min (A) or
60min (B). The relative P-JNK:f-actin z-score was determined for each
dsRNA. The red dashed lines represent z-score values of + or 2 2.58. Key
was identified as the strongest suppressor of dJNK phosphorylation at
15min and 60min PGN exposure (A,B), whereas Tak1 was identified as
the strongest enhancer of dJNK phoshorylation at 15min PGN exposure
(B). (C) dsRNAs that modified dJNK phosphorylation in response to PGN
were grouped according to biological functions. The biological
functions for enhancers of dJNK phosphorylation with a z-score below
22.58 at 15min PGN exposure are presented (left panel). Additionally,
the biological functions for suppressors of dJNK phosphorylation with a
z-score above 2.58 at 15min and 60min PGN-exposure are presented
(right panel). In addition to recognizable groups, the dsRNA screen
identified a large number of Drosophila genes with unknown biological
functions as modifiers of PGN-induced dJNK phosphorylation. (D) Heat
map of z-score values for S2 cells depleted of known Imd pathway
components and exposed to PGN for 15min or 60min. Fifteen core IMD
pathway components were identified in the screen as either
suppressors (z-scores above 1.96) or enhancers (z-scores below
21.96) of PGN-induced dJNK phosphorylation respectively.
doi:10.1371/journal.ppat.1000655.g002
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minutes. We confirmed that both dsRNAs deplete Pvr by
monitoring Pvr protein levels relative to actin in S2 cell lysates
using Pvr specific antibodies (Figure 3D). Treatment of S2 cells
with Pvr dsRNA 1 or 2 reduced relative Pvr protein levels to 1.6%
and 15.6% of the control, respectively. In addition, depletion of
Pvr by either dsRNA significantly increased PGN-induced dJNK
phosphorylation at fifteen minutes (Figure 3E). Thus, we conclude
that Pvr suppresses PGN-dependent dJNK phosphorylation.
pvf2 and pvf3 are IMD/dJNK-Responsive Transcripts
While a previous dsRNA screen hinted at a role for Pvr in the
IMD pathway [14], Pvr is primarily known for its role in Drosophila
ERK signaling and cell migration. To investigate the involvement
of the Pvr pathway in attenuation of dJNK activation, we
determined the dJNK:f-actin z-score for each member of the Pvr/
dERK axis in the primary screen. As a comparison, we also
determined the dJNK:f-actin z-scores for members of the wingless
pathway – a signal transduction pathway with no know interaction
with the IMD/dJNK module. As expected, our data do not
indicate any major interactions between the wingless and IMD/
dJNK pathways. In contrast, our data consistently indicate that the
Pvr/dERK pathway negatively regulates dJNK activation
(Figure 4A). Ablation of the Pvr ligands Pvf2 and Pvf3; Pvr;
established dERK adaptors; Ras and dERK resulted in consid-
erably increased PGN-mediated dJNK phosphorylation.
We then asked if IMD pathway activation results in expression
of Pvr ligands. Treatment of S2 cells with PGN resulted in a minor
decline in the expression of pvf1 and significant increases in the
levels of pvf2 and pvf3 expression (Figure 4B). Induction of pvf2 and
pvf3 reached maximal levels within one hour of PGN treatment
and reverted to basal levels by six hours. These expression patterns
are reminiscent of other IMD/dJNK-responsive transcripts. To
confirm that pvf2 and pvf3 are dJNK-responsive transcripts, we
Figure 3. Pvr is a negative regulator of dJNK phosphorylation in the IMD pathway. (A,B) Quantification of PGN-induced dJNK
phosphorylation relative to f-actin (A) or total JNK (B). S2 cells were incubated with the indicated dsRNAs and exposed to PGN at 0min, 15min or
60min as indicated. Key and dTak1 dsRNA were used as modifier dsRNA controls, whereas Toll and CG11318 dsRNA were used as non-modifier dsRNA
controls. Cells were stained with anti-P-JNK antibody and dJNK phosphorylation was standardized to f-actin (A) and total dJNK (B). Data are presented
as the mean of two independent experimental values and error bars indicate + SEM. The grey dashed line represents the mean dJNK phosphorylation
value for Toll dsRNA and dsRNAs that significantly modulated dJNK phosphorylation from this value are indicated (*=p-value ,0.05, **=p-value
,0.01). Secondary dsRNA analysis recapitulates the dJNK phosphorylation values from the primary screen. (C) A partial genetic and physical
interaction network of dJNK phosphorylation modifiers. Modulators of dJNK phosphorylation with z-scores greater than 1.96 or less than 21.96 were
grouped in an interaction network using known genetic and physical interaction databases. Within this network, Pvr (black circle) and dJnk (white
circle) are connected directly and through a number of intermediate genes (yellow circles). The Pvr and dJnk interaction network also connects to IMD
pathway (blue circles). (D) Quantitative Western blot analysis of lysates from S2 cells treated with either Pvr or GFP dsRNA. Lysates were probed with
anti-Pvr (top blot) and anti-actin (bottom blot) antibodies. Pvr levels were quantified relative to actin (top graph). Data are presented as mean of three
independent experiments and error bars indicate + SEM. Both Pvr dsRNA molecules deplete Pvr in S2 cells. (E) Quantification of PGN-induced dJNK
phosphorylation. S2 cells were treated with GFP dsRNA as a control or two independent non-overlapping dsRNA targeting Pvr as indicated. Cells
were exposed to PGN and dJNK phosphorylation was monitored relative to total dJNK. P-JNK:JNK values at 0h PGN exposure with GFP dsRNA were
assigned a value of 1 and the remaining P-JNK:JNK values are reported relative to these data. Data is expressed as the mean of two independent
experiments and the error bars represent +/2 SEM. Significant differences in pJNK values are indicated (*=p-value,0.05, **=p-value,0.01).
Depletion of Pvr increases PGN-induced dJNK phosphorylation at 15min, indicating that Pvr negatively regulates dJNK activation in the IMD pathway.
doi:10.1371/journal.ppat.1000655.g003
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monitored the subsequent levels of pvf2 and pvf3 expression in
response to PGN. Our data showed that SP600125 completely
blocked the PGN-dependent expression of pvf2 and pvf3
(Figure 4C). Likewise, we observed a significant reduction in
PGN-dependent pvf2 induction in cells depleted of PGRP-LC
(Figure 4D) or dMKK4/dMKK7 (Figure 4E), confirming a
requirement for the IMD/dJNK cassette in pvf2 induction by
PGN. In summary, these data show that activation of the IMD
pathway results in the dJNK-dependent expression of the Pvr
ligands Pvf2 and Pvf3 and that the Pvr/dERK pathway attenuates
dJNK activation.
Pvr Suppresses PGN-induced Rel Signaling
Given that Pvr suppresses dJNK signaling in the IMD pathway,
we asked if Pvr also modulates Rel signaling events. To determine if
Pvr depletionaffects Relsignalinginthe IMDpathway, we depleted
S2 cells of Pvr with two independent non-overlapping Pvr dsRNAs
and monitored PGN-induced AMP expression. Specifically, we
monitored expression of the Rel-responsive AMPs dipt and att.
Depletion of Pvr by either dsRNA profoundly strengthened PGN-
induced expression of att and dipt in comparison to control S2 cells
(Figure 5A, B). Additionally, Pvr depletion significantly increased
thebasalexpression levels ofboth attanddipt, intheabsenceofPGN
stimulation. In fact, the basal levels of att or dipt expression in cells
treated with Pvr dsRNA are approximately equal to the PGN-
induced expression levels in cells treated with GFP control dsRNA.
These data show that loss of Pvr in S2 cells results in an increase in
both the uninduced and the PGN-induced expression of AMPs.
To confirm that the increased AMP expression observed upon
Pvr loss proceeds through Rel, we then examined the expression of
att in S2 cells that were simultaneously treated with Pvr and Rel
dsRNA. As expected, depletion of Pvr increased the PGN-
mediated expression of att (Figure 5C). In contrast, PGN-mediated
expression of att was greatly reduced in cells treated with a
combination of Rel and Pvr dsRNA. Thus, our data indicate that
the bulk of Pvr RNAi-dependent increases in att expression
proceed through the IMD/Rel module. In agreement with a role
for the Pvr pathway in reducing att expression, we also observed
increased att induction in cells treated with Ras85D dsRNA
(Figure 5D). As Pvr loss leads to enhanced Rel-mediated AMP
expression, we then asked if Pvr affects Rel cleavage or Rel
phosphorylation. Whereas depletion of Pvr greatly sensitized S2
cells to PGN-dependent induction of dJNK phosphorylation (e.g.
compare lanes 5 and 11, Figure 5E), we did not detect alterations
in the pattern of PGN-induced Rel cleavage in S2 cells treated
with Pvr dsRNA (Figure 5E). In contrast, we consistently detected
prolonged and increased PGN-responsive phosphorylation Rel (P-
Figure 4. pvf2 and pvf3 are immune Induced dJNK-dependent transcripts. (A) Heat map analysis of known Pvr pathway genes compared to
known wg pathway genes at 15 min PGN-exposure. 15min PGN-induced dJNK:f-actin z-scores were ordered from highest to lowest and organized
according to percentile intervals. Genes colored more red indicate suppressors of PGN-induced dJNK phosphorylation while genes colored more green
indicate enhancers of PGN-induced dJNK phosphorylation. Pvr pathway components were consistently identified as suppressors of PGN-induced dJNK
phosphorylation.(B)Quantitativereal-time PCRanalysis ofstandardizedpvf1,2 and3 expressionin S2cellstreatedwithPGNfor theindicatedtimes.The
uninduced expression levels for pvf1,2 and 3 were given values of 1 and the remaining pvf1,2 and 3 expression values are reported relative to these
values.Dataarepresentedas meanof threeindependentexperimentsanderrorbarsindicate the+ SEM.Significantdifferencesinexpressionvaluesare
indicated (**=p-value ,0.01). (C) Quantitative real-time PCR analysis of standardized pvf1,2 and 3 expression in S2 cells or S2 cells treated with
SP600125. S2 cells were incubated with SP600125 and PGN as indicated. The uninduced expression levels for pvf1,2 and 3 were given values of 1 and
the remaining pvf1,2 and 3 expression values are reported relative to these values. Data are presented as mean of three independent experiments and
error bars indicate the + SEM. Significant differences in P-JNKvaluesare indicated (*=p-value,0.05, **=p-value ,0.01). (D) Quantitative real-time PCR
analysis of standardized pvf2 expression in S2 cells incubated with GFP or PGRP-LC dsRNA and treated with PGN as indicated. pvf2 expression levels of
unstimulatedS2cellstreatedwithGFPdsRNAwereassigneda valueof 1 andthe remainingpvf2expressionvaluesarereported relative tothesevalues.
Data are presented as mean of three independent experiments and error bars indicate the + SEM. Significant differences in P-JNK values are indicated
( **=p-value ,0.01). (E) Quantitative real-time PCR analysis of standardized pvf2 expression in S2 cells incubated with GFP or a combination of dMKK4/
7 dsRNA and treated with PGN as indicated. pvf2 expression levels of unstimulated S2 cells treated with GFP dsRNA were assigned a value of 1 and the
remaining pvf2 expression values are reported relative to these values. Data are presented as mean of three independent experiments and error bars
indicate the + SEM. Significant differences in P-JNK values are indicated ( *=p-value ,0.05).
doi:10.1371/journal.ppat.1000655.g004
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indicate that Pvr negatively regulates the PGN-induced phosphor-
ylation of both dJNK and Rel in the IMD pathway.
Pvr Signaling Suppresses PGN-dependent IMD Pathway
Activation
Given our findings that Pvr depletion increases AMP expression,
we asked if activation of Pvr suppresses the IMD pathway. We
monitored dERK phosphorylation to visualize Pvr signaling, as Pvr
engagement results in activation of dERK in S2 cells. Previous
reports demonstrated that Pvr ligands in conditioned medium (CM)
from the Drosophila KC167 cell line activates Pvrsignalingin S2 cells
[44]. Likewise, we observed a requirement for Pvr in KC167 CM-
induced dERK phosphorylation in S2 cells (Figure 6A). Quantifi-
cation of relative dERK phosphorylation levels showed that Pvr
dsRNA treatment decreased CM-induced dERK phosphorylation
21 fold (Figure 6B). To examine the effect of Pvr signaling on AMP
expression, we treated S2 cells with GFP or Pvr dsRNA and
monitored PGN-induced att expression levels 6h after exposure to
CM (Figure 6C). Consistent with the role of Pvr as a suppressor of
Rel signaling, we found that CM significantly decreased PGN-
induced att expression. The phenotype is not an indirect effect of
CM on PGN or other aspects of the IMD pathway, as dsRNA-
mediated depletion of Pvr from S2 cells abrogated the suppressive
effects of CM on att expression (Figure 6C). Thus, we conclude that
activation of Pvr blocks PGN-responsiveness in S2 cells.
As Pvr signaling often proceeds through dERK and the bulk of
the Ras/dERK pathway yielded Pvr-like phenotypes in our
primary screen, we then tested if dERK phosphorylation is
required for CM suppression of PGN-induced att expression.
Treatment of S2 cells with the MEK1 inhibitor PD98059
decreased CM-induced dERK phosphorylation 3.2 fold relative
to S2 cells treated with CM alone (Figure 6D, E). To test the effect
of dERK inhibition on CM-mediated suppression of att expression,
we pretreated S2 cells with PD98059 prior to exposure to PGN
and CM (Figure 6F). CM suppressed the PGN-induced expression
of att by 7.7 fold. However, we detected significant restoration of
PGN-induced att expression in S2 cells treated with CM and
PD98059. These data indicate that signal transduction through a
Pvr/dERK axis attenuates activation of the IMD pathway.
Pvr Suppresses AMP Production In Vivo
We then asked if Pvr suppresses IMD pathway activity in vivo.
To reduce Pvr activity in whole animals, we expressed Pvr dsRNA
Figure 5. Pvr depletion increases antimicrobial peptide production in S2 cells. (A) Quantitative real-time PCR analysis of standardized att
expression in S2 cells incubated with either GFP or two distinct Pvr dsRNA. S2 cells were treated with PGN where indicated. att expression levels of
unstimulated S2 cells treated with GFP dsRNA were assigned a value of 1 and the remaining att expression values are reported relative to these
values. Data are presented as mean of two independent experiments and error bars indicate the + SEM. (B) Quantitative real-time PCR analysis of
standardized dipt expression in S2 cells incubated with either GFP or two distinct Pvr dsRNA. S2 cells were treated with PGN for 6h where indicated.
dipt expression levels of unstimulated S2 cells treated with GFP dsRNA were assigned a value of 1 and the remaining dipt expression values are
reported relative to these values. Data are presented as mean of two independent experiments and error bars indicate + SEM. (C) Quantitative real-
time PCR analysis of standardized att expression in S2 cells incubated with GFP or Pvr dsRNA in combination with Rel dsRNA. S2 cells were treated
with the indicated dsRNAs and unstimulated or stimulated with PGN for 6h as indicated. att expression levels of unstimulated S2 cells treated with
GFP dsRNA were assigned a value of 1 and the remaining att expression values are reported relative to these values. Data are presented as mean of
three independent experiments and error bars indicate the + SEM. Significant differences in att expression values are indicated with a p-value. (D)
Quantitative real-time PCR analysis of standardized att expression in S2 cells incubated with GFP or Ras85D dsRNA and treated with PGN as indicated.
att expression levels of unstimulated S2 cells treated with GFP dsRNA were assigned a value of 1 and the remaining att expression values are reported
relative to these values. Data are presented as mean of two independent experiments and error bars indicate the + SEM. (E) Western blot analysis of
lysates from S2 cells incubated with GFP dsRNA (lanes 1–6) or Pvr dsRNA (lanes 7–12). S2 cells were untreated or treated with PGN in increasing ten-
fold gradations of LPS from 5610
24mg/ml to 5mg/ml. Lysates were probed with anti-Rel (top panels), anti-P-JNK (middle) and anti-JNK (bottom panel).
(F) Western blot analysis of lysates from S2 cells incubated with Pvr dsRNA (lane 1–6) or GFP dsRNA (lanes 7–12) and treated with PGN for the
indicated period. Lysates were probed with anti-P-Rel (top panel), anti-P-JNK (middle) and anti-JNK (bottom panel).
doi:10.1371/journal.ppat.1000655.g005
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PLoS Pathogens | www.plospathogens.org 7 November 2009 | Volume 5 | Issue 11 | e1000655Figure 6. Pvr inhibits antimicrobial peptide production in S2 cells. (A) Western blot analysis of lysates from S2 cells incubated with GFP
dsRNA (lane 1–2) or Pvr dsRNA (lanes 3–4). S2 cells were exposed to KC167 cell conditioned media (CM) where indicated to induce MAPK
phosphorylation. Lysates were probed with antibodies specific for P-MAPK (top panel), and actin (bottom panel). Data is representative of three
individual experiments. (B) Relative quantification of P-MAPK levels from (A). P-MAPK levels were standardized to actin levels for each treatment
group. The unstimulated GFP dsRNA treated P-MAPK:actin value was given a value of 1 and the remaining P-MAPK:actin values are reported relative
to this value. (C) Quantitative real-time PCR analysis of att expression in S2 cells incubated with GFP dsRNA (columns 1–3) or Pvr dsRNA (columns 4–
5). S2 cells were treated with KC167 CM, and PGN as indicated. att expression levels in unstimulated S2 cells treated with GFP dsRNA were assigned a
value of 1 and the remaining att expression values are reported relative to these values. Data are presented as the mean of three independent
experiments and error bars indicate + SEM. The significance of CM treatment on att expression relative to the untreated samples is indicated (*=
p-value ,0.05). CM does not suppress att expression in the absence of Pvr. (D) Western blot analysis of lysates from S2 cells treated with the MEK1
inhibitor PD98059 followed by exposure to PGN, and KC167 CM as indicated. Lysates were probed with anti-P-MAPK (top panel), and anti-actin
(bottom panel) antibodies. (E) Relative quantification of P-MAPK levels in panel D. P-MAPK levels were standardized to actin levels for each treatment
group. The untreated P-MAPK:actin value was given a value of 1 and the remaining P-MAPK:actin values are reported relative to this value. (F)
Quantitative real-time PCR analysis of att expression levels in S2 cells (column 1–3) or S2 cells treated with PD98059 (column 4). S2 cells were
incubated with KC167 CM, and PGN as indicated. att expression levels in unstimulated S2 cells were assigned a value of 1 and the remaining att
expression values are reported relative to these values. Data are presented as the mean of three independent experiments and error bars indicate +
SEM. Inhibition of MEK1 activation with PD98059 significantly restored att expression in response to KC167 CM.
doi:10.1371/journal.ppat.1000655.g006
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immune response of infected wild type flies to flies that express
Pvr-IR. Specifically, we monitored the expression of the Rel-
responsive transcript att in uninfected flies (control) and flies that
were pricked with a needle coated in E. coli (infection). Strikingly,
we noticed that in vivo depletion of Pvr significantly enhanced
infection-mediated att expression in three separate experiments in
two separate Pvr-IR fly lines (Figure 7). These data indicate that
depletion of Pvr from adult flies results in increased IMD pathway
activity in vivo and support a role for Pvr as a negative regulator of
Imd pathway activity.
Discussion
Signal transduction through the JNK family of MAP kinases is a
central element of vertebrate and invertebrate innate immune
responses to infectious microbes. In addition, JNK activation
contributes to the regulation of essential cellular processes, such as
differentiation, apoptosis and directed cell movements [45,46,47].
The pleiotropic developmental and homeostatic requirements for
JNK activity combined with functional redundancies among JNK
pathway member isoforms hampered large-scale evaluations of
JNK in model systems. In this study, we present the first whole-
genome RNAi screen for modifiers of JNK activation to be
performed in any metazoan. We specifically addressed the
regulation of JNK activation in the context of innate immunity.
We believe that Drosophila S2 cells present an ideal system for the
study of the JNK signal transduction pathway, as S2 cells are
readily accessible to large-scale RNAi screens, reproduce key
elements of the Drosophila innate immune response and serve as a
convenient gateway for whole animal studies in the genetically
tractable Drosophila melanogaster. Given the evolutionary conserva-
tion of the JNK signal transduction pathway, we believe that our
studies are of direct relevance to JNK activity in the immune
response of higher organisms.
We also consider it likely that we have serendipitously identified
general regulators of the JNK pathway with roles that extend
beyond immune signaling. For example, we identified core
elements of the JNK activation cassette such as misshapen (msn,
M4K ortholog), hemipterous (hep, MKK4 orthologs) and dMKK7
(MKK7 ortholog) as required for activation of dJNK in the IMD
pathway. A recent RNAi-based survey of four hundred eighty two
Drosophila genes identified seventy seven core JNK pathway
regulators [48]. Specifically, the authors detected gene products
that modified basal dJNK phosphorylation levels in a number of
genetically compromised backgrounds. In our assay, we excluded
six of these JNK modifiers from analysis as they caused a
significant depletion of f-actin. Of the remaining seventy one gene
products, twenty three were significant modifiers of PGN-
mediated dJNK phosphorylation (Figure S1). Thus, despite the
large differences between both screens, we noticed a considerable
overlap in our identification of dJNK modifiers.
We consider the false negative rate for IMD pathway members
a more pertinent measure of the success of our screen. In contrast
to previous RNAi screens of signal transduction pathways, our
assay did not rely on indirect reporter assays. Instead, we
measured the contribution of each annotated gene within the fly
genome to the IMD-responsive phosphorylation of dJNK. We
believe that the direct quantitative nature of our assay combined
with the ease of RNAi in S2 cells greatly minimizes the likelihood
of false negatives in the primary screen. Indeed, preliminary
analysis of our primary screen data identified the bulk of the IMD
signal transduction pathway (PGRP-LC, Imd, dFADD, Dredd,
Pirk, dTAB2, dIAP2, dTAK1, dMKK4/7, dJNK, dFos, Key, Ird5
and Rel) as essential modifiers of JNK activation in the IMD
pathway. In each case, the phenotype was consistent with the
established molecular function of the respective IMD pathway
element as either negative or positive modifiers of JNK activation.
Thus, we are satisfied that false negatives do not obfuscate
interpretation of our data in any meaningful manner. Ironically,
the only anticipated hit we failed to identify was dJun [49].
The Drosophila receptor tyrosine kinase Pvr shows considerable
similarity to members of the mammalian PDGF and VEGF
receptor families and Pvr is considered an evolutionary ancestor of
PDGF/VEGF receptors [38]. Pvr is activated in a partially
redundant manner by three PDGF/VEGF-type ligands, Pvf1-3
[37,38,42,50]. Initial studies implicated Pvr as a guidance receptor
for cell migratory cues in embryonic hemocyte migration, oocyte
border cell migration, thorax closure and dorsal closure of male
terminalia [36,37,38,39,42]. The molecular basis for Pvr-mediated
cell movements requires clarification. While functional redundan-
cies appear to exist between individual Pvf ligands, several studies
indicate a potential preference for Pvf-1 in the guidance of cell
migration [40,42]. In thorax closure and border cell migration,
migratory cues proceed through the Pvr adaptor proteins Mbc,
Ced-12 and Crk [36,39]. In the case of thorax closure and dorsal
closure of male genitalia it appears that Pvr induces the
corresponding cell movements through the JNK pathway. Thus,
Pvr appears to be a positive regulator of JNK activity in the
context of cell movements. This is logical given the extensive
involvement of JNK in the coordination of cell migration during
development. However, our data strongly indicate that Pvr is a
negative regulator of JNK activity during immune signaling. We
did not detect any requirements for Mbc, Ced-12 or Ckr in the
regulation of innate immune signaling. These data suggest that
Figure 7. Pvr attenuates infection-induced antimicrobial pep-
tide production in vivo. Quantitative real-time PCR analysis of att
expression in hs-gal4/+ control flies (columns 1–2), hs-gal4/uas-Pvr-IR1
flies (columns 3–4) and hs-gal4/+; uas-Pvr-IR2/+ flies (columns 5–6). Flies
were uninfected or infected through septic injury with E. coli as
indicated. att expression levels of uninfected controls were assigned a
value of 1 and the remaining att expression values are reported relative
to these value. Data are presented as mean of three independent
experiments and error bars indicate the + SEM. Significant differences in
att expression are indicated (**=p-value ,0.01).
doi:10.1371/journal.ppat.1000655.g007
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tween the impacts of Pvr on immune responses and cell migration.
In addition to requirements for Pvr in cell migration, a parallel
body of literature indicates a distinct function for Pvr in the
regulation of hemocyte proliferation. The disruptions to embry-
onic hemocyte migration in pvr mutants were originally interpreted
to indicate that Pvr detects migratory guidance cues in hemocytes
[37]. More recent studies demonstrated that expression of the anti-
apoptotic p35 molecule in the hemocytes of pvr mutants rescues
the majority of the migratory phenoptye [51]. Further studies
confirmed that the bulk of the pvr hemocyte phenotype is the result
of cell death and that there are only minor guidance requirements
for Pvr in hemocyte migration. Pvr activates the dERK pathway,
which induces hemocyte proliferation [51,52]. Consistent with a
role for Pvr in hemocyte proliferation, overexpression of Pvf2
drives massive hemocyte proliferation in vivo and incubation of
embryonic mbn-2 hemocytes with Pvr antibodies blocks cellular
proliferation in a dose-dependent manner [50]. In contrast,
overexpression of Pvf-1 did not substantially alter hemocyte
proliferation in vivo and a recent study indicated that proliferative
signals for hemocytes are preferentially provided by Pvf2 and Pvf3
[52]. In this context, we consider it particularly striking that our
data reveal that signal transduction through the IMD pathway
results in dJNK-mediated expression of Pvf2 and Pvf3.
Our study reveals a novel role for the Pvr/dERK pathway in the
attenuation of the IMD pathway and illuminates our understanding
of the network of regulatory checks and balances that fine tune the
level of IMD/dJNK activity. Our data are most consistent with a
model whereby activation of the IMD pathway results in dJNK-
dependent expression of the Pvr ligands Pvf2 and Pvf3. Pvr then
signals through dERK to negatively regulate the IMD pathway. On
a molecular level, our data show that Pvr signaling dampens the
dTAK1-dependent phosphorylation of dJNK and Rel. However,
we believe that our data may also uncover an additional
physiological role for Pvr. We speculate that the infection-driven
production of Pvf2 and Pvf3 engages Pvr receptors on hemocytes
and thereby stimulates the Ras/dERK-responsive proliferation of
hemocytes. Such an increase in hemocytes numbers would provide
a timely measure for the phagocytic elimination of invading
extracellular microbes at early stages of infection.
We find it intriguing that proliferative signals inhibit activation
of immune pathways. It may be that both processes require major
metabolic commitments and that hemocytes preferentially reserve
resources for proliferation. An alternative and non-exclusive
hypothesis reflects the primary role of Drosophila hemocytes in
immunity. Hemocytes are the major phagocytic cell type in
Drosophila and are ideally suited for the engulfment of extracellular
microbes. We consider it possible that induction of immune
responses drives Pvr-mediated proliferation of hemocytes to
facilitate rapid neutralization of extracellular microbes through
phagocytosis. In this situation, it is advantageous for proliferative
signals to suppress JNK activation, as hyper or prolonged
activation of JNK in Drosophila often results in cell death.
Preliminary data in our lab suggest that links between Pvr and
immune signaling may be evolutionarily conserved, as we detected
suppression of NF-kB activity through the PDGF receptor
superfamily member c-Kit in human cell culture assays (Anja
Schindler and Edan Foley, unpublished).
Materials and Methods
Cell Culture
Drosophila S2 cells and KC167 cells were cultured at 25uCi n
HyQ TNM-FH medium (HyClone) supplemented with 10% heat
inactivated fetal bovine serum (Invitrogen), 50U/ml of penicillin
and 5 mg/ml of streptomycin (GIBCO). Serum-free S2 cells were
incubated in SFX-INSECT medium (HyClone) supplemeted with
50U/ml of penicillin and 5 mg/ml of streptomycin (GIBCO).
PGN-dependent dJNK activation was inhibited in 10
6 S2 cells in
1ml of culture media with the addition of 25mM SP600125 for 1h
prior to PGN-exposure.
RNAi
The dsRNA library employed in this screen is an extension of a
partial-genome library described previously [53]. The remainder
of the library was purchased from Open Biosystems. In-Cell
Western quantitative analysis was carried out as described in [54].
Briefly, S2 cells were incubated at 1.5610
5 cells/well in 96 well
plate in 20% conditioned media and 80% serum-free culture
media with 10mg/ml dsRNAs at 25uC for three days. Cells were
exposed to 50mg/ml LPS (Sigma) containing contaminating
amounts of PGN for 15 or 60 min. Cell were washed with PBS,
fixed in PBS + 3.7% formaldehyde, permeablized in PBS + 0.1%
Triton-X 100 and blocked in blocking buffer (LI-COR Bioscienc-
es). Cells were probed with mouse anti-active-JNK (Cell Signaling)
and washed with PBS + 0.1% Tween-20. P-JNK staining was
detected with fluorescently labeled goat anti-mouse secondary
antibodies and f-actin was stained with fluorescently labeled
phalloidin (Invitrogen). Cells were washed in PBS + 0.1% Tween
and P-JNK and f-actin levels were quantified with an Aerius
automated imaging system (LI-COR Biosciences) following the
manufacturers recommendations. In secondary ICW analyses P-
JNK was monitored relative to JNK by replacing phalloidin
staining with rabbit anti-JNK (Santa Cruz Biotechnology) and
fluorescently labeled goat anti-rabbit antibodies.
Data Analysis
For the RNAi screen, the raw fluorescent trimmed mean level
was determined for P-JNK and f-actin channels in each well and
the relative P-JNK:f-actin value was calculated. We applied z-
score analysis to normalize P-JNK:f-actin values across the entire
screen. Z-scores were calculated by subtracting the sample value
by the plate median value and dividing by the plate standard
deviation. The z-score assumes normal distribution and represents
the standard deviation of every P-JNK:f-actin value from the plate
median for each dsRNA treatment. Z-scores above 2.58 or below
22.58 represent the 99% confidence interval and z-scores above
1.96 or below 21.96 represent the 95% confidence interval. The f-
actin z-scores were also calculated for every well on each plate and
dsRNA treatments resulting in f-actin z-scores below 22.58 (99%
CI) were excluded from further analysis to eliminate actin
modifiers and lethal dsRNAs. We considered dsRNAs that
modified P-JNK:actin z-scores outside the 95% confidence interval
as hits in the screen. To identify genetic or physical interactions
among hits from our screen, all hits were probed in the Drosophila
interactions database [55] and visualized with the IM browser
(http://www.droidb.org/IMBrowser.jsp). For analysis of att ex-
pression in the infection model, the DCt values were standardized
to an internal control between qRt-PCR runs. The triplicate 0h
DCt values were averaged and the DDCt values were calculated
relative to these values. The fold change was calculated for each
sample and the 0h time point was set to one for each fly line. The
SEM was calculated for each time point. Statistical significance of
experimental values was expressed as p-values of less than .01 (**)
or .05 (*), as calculated by a Student’s t-test. We performed two-
tailed Student’s t-tests with two-samples of equal variance to
calculate a p-value of experimental values relative to control
values.
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Western blot analysis was performed on 10
6 cells lysed in
sample buffer, vortexted and incubated at 95uC for 5min.
Proteins were separated by SDS-PAGE electrophoresis and were
transfer to nitrocellulose membrane by semidry transfer. Mem-
branes were blocked in blocking buffer (LI-COR Biosciences) and
probed with mouse anti-active-JNK (Cell Signailing), rabbit anti-
JNK (Santa Cruz Biotechnology), rabbit anti-pan-actin (Cell
Signaling), mouse anti-actin (Sigma), rabbit anti-active MAPK1/
2 (Upstate), mouse anti-HA (Sigma) or rat anti-Pvr. Western blot
analysis of P-Rel and Rel cleveage was performed as described in
[28]. All secondary antibodies were purchased from Invitrogen.
Proteins levels were quantified with an Aerius automated imag-
ing system (LI-COR Biosciences) following the manufacturers
recommendations.
Quantitative Real-Time PCR
Antimicrobial peptide production was monitored in S2 cells and
fliesbyqRT-PCR.TotalRNAwasextracted from 10
6 S2cellsor10
adult flies using Trizol (Invitrogen) following the manufacturers
instructions. cDNA was created from 2mg of RNA using Superscript
III (Invitrogen) and oligo-dT primers (Invitrogen), according to the
manufacturers instructions. We monitored transcript amplification
witha Realplex2PCRmachine (Eppendorf)usingSYBRgreenasa
detection reagent (Invitrogen). We used the following primers to
monitor the expression of the corresponding gene products; actin
forward 59-TGCCTCATCGCCGACATAA-39, actin reverse 59-
CACGTCACCAGGGCGTAAT-39; att forward 59-AGTCA-
CAACTGGCGGAC-39, att reverse 59-TGTTGAATAAATTGG-
CATGG-39; dipt forward 59-ACCGCAGTACCCACTCAATC-39,
dipt reverse 59-ACTTTCCAGCTCGGTTCTGA-39; pvf1 forward
59-GCGCAGCATCATGAAATCAACCG-39, pvf1 reverse 59-
TGCACGCGGGCATATAGTAGTAG-39; pvf2 forward 59-TC-
AGCGACGAAACGTGCAAGAG-39, pvf2 reverse 59-TTTG-
AATGCGGCGTCGTTCC-39; pvf3 forward 59-AGCCAA-
ATTTGTGCCGCCAAG-39, pvf3 reverse 59- CTGCGATGCT-
TACTGCTCTTCACG-39. All transcript expression values were
normalized to actin and were quantified relative to a control using
the DDCt method.
Inhibition/Activation of Pvr
We depleted Pvr from S2 cells with two non-overlapping
dsRNAs. We designed the following primers to amplify the
associated dsRNA template DNA in a two step PCR using 59-
GGGCGGT-39 as an anchor sequence; Pvr1 forward 59-
GGGCGGGTGATGACTACATGGAGATGAGCC-39, Pvr1
reverse 59-GGGCGGGTATACCTTCGTTGCTCCTTCTCG-
39; Pvr2 forward 59-GGGCGGGTCTCCTGATTTTGCG-
GATCTC-39, reverse 59-GGGCGGGTGTCTTGGGATCGG-
TTCTTGA-39; GFP forward 59-GGGCGGGTACGTAAA-
CGGCCACAAG-39, GFP reverse 59-GGGCGGGTCTCAGG-
TAGTGGTTGTC-39. We performed a second PCR amplifica-
tion of anchor-tagged template DNA with the T7 promoter
containing primer 59-TAATACGACTCACTATAGGGAGAC-
CACGGGCGGGT-39. dsRNA was amplified from template
DNA using T7 RNA polymerase at 25uC for 6h and annealed
by cooling from 90uCt o3 0 uC. S2 cells were depleted of Pvr using
Pvr1 dsRNA unless stated otherwise. 10
6 S2 cells were treated with
dsRNA for 4 days in 1ml culture media to deplete Pvr. The Pvr
pathway was activated in S2 cell using 1:1 dilution of fresh culture
media in conditioned media (CM) collected from 4 day cultures of
KC167 cells. Pvr dependent dERK phosphorylation was inhibited
in 10
6 S2 cells in 1ml of culture media with the addition of 50mM
PD98059 for 1h prior to CM exposure.
Fly Husbandry
Drosophila strains were cultured on standard cornmeal medium
(http://flystocks.bio.indiana.edu/Fly_Work/media-recipes/
bloomfood.htm) at 25uC. hs-gal4 flies were obtained from Dr.
Sarah Hughes and uas-PvrIR flies were obtained from the Vienna
Drosophila RNAi Center. For in vivo knock down of Pvr, UAS-PvrIR
flies were crossed with hs-gal4 flies or w
118 flies. 1 day old flies were
heat-pulsed eight times at 37uC for 1h to initiate the expression of
the RNAi construct and returned to 25uC for 5h over 48 hours.
Infection was monitored in flies that were either uninjured
(control), or pricked with a tungsten needle dipped in a pellet of
DH5a E. coli bacteria (infection).
Supporting Information
Figure S1 P-JNK screen comparative analysis. Comparative
analysis of 15min and 60min PGN-induced P-JNK:f-actin screen
results relative to Bakal C. et. al. 2008 [48]. 15min and 60min P-
JNK:f-actin z-scores were ordered from highest to lowest and
organized according to confidence intervals. Genes identified as
modifiers of dJNK activity in Bakal C. et. al. 2008 were cross
referenced with the PGN-induced percent P-JNK:f-actin at 15min
and 60min. Genes indicated in more red demonstrated a stronger
suppressive phenotype on PGN-induced JNK phosphorylation,
while gene indicated in more green demonstrated a stronger
enhancing phenotype on PGN-induced dJNK phosphorylation.
Vertical lines indicate genes that suppress JNK phosphorylation in
the top 95th percentile and genes that enhance JNK phosphor-
ylation in the bottom 5th percentile.
Found at: doi:10.1371/journal.ppat.1000655.s001 (0.50 MB TIF)
Table S1 z-score analysis of dsRNA effects on 15 and 60 min
PGN-induced dJNK phosphorylation. In-cell Western z-scores
were calculated from P-JNK:f-actin values from S2 cells incubated
with 15,683 dsRNAs and treated with PGN for 15 or 60 min. Z-
scores are ordered from highest to lowest 15 min z-score. dsRNAs
that modified f-actin levels below the 95% at 15 min PGN
treatment were excluded. Each dsRNA is identified by its Celera
Genome (CG) number or by its Heidelberg Drosophila Consor-
tium identification number (HCDID) and general function.
Found at: doi:10.1371/journal.ppat.1000655.s002 (0.96 MB
PDF)
Table S2 z-score analysis of dsRNA-mediated depletion of
enhancers of PGN-induced dJNK phosphorylation. In-cell
Western z-scores were calculated from P-JNK:f-actin values from
S2 cells incubated with 15,683 dsRNAs and treated with PGN for
15 min. dsRNAs that modified P-JNK:f-actin z-scores below 1.96
(95% CI) are ordered from smallest to highest z-score. The fold
change in dJNK phosphorylation relative to the plate median is
shown alongside the z-score values. Each dsRNA is identified by
its symbol and Celera Genome (CG) number or by its Heidelberg
Drosophila Consortium identification number (HCDID).
Found at: doi:10.1371/journal.ppat.1000655.s003 (0.33 MB
DOC)
Table S3 z-score analysis of dsRNA-mediated depletion of
suppressors of 15 min PGN-induced dJNK phosphorylation. In-
cell Western z-scores were calculated from P-JNK:f-actin values
from S2 cells incubated with 15,683 dsRNAs and treated with
PGN for 15 or 60 min. dsRNAs that modified 15 min PGN-
induced P-JNK:f-actin z-scores above 1.96 (95% CI) are ordered
from highest to lowest z-score. The fold change in dJNK
phosphorylation relative to the plate median is shown alongside
the z-score values for both 15 and 60 min time points. Each
dsRNA is identified by its symbol and Celera Genome (CG)
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number (HCDID).
Found at: doi:10.1371/journal.ppat.1000655.s004 (1.05 MB
DOC)
Table S4 z-score analysis of dsRNA-mediated depletion of
suppressors of 60 min PGN-induced dJNK phosphorylation. In-
cell Western z-scores were calculated from P-JNK:f-actin values
from S2 cells incubated with 15,683 dsRNAs and treated with
PGN for 15 or 60 min. dsRNAs that modified 60 min PGN-
induced P-JNK:f-actin z-scores above 1.96 (95% CI) are ordered
from highest to lowest z-score. The fold change in dJNK
phosphorylation relative to the plate median is shown alongside
the z-score values for both 15 and 60 min time points. Each
dsRNA is identified by its symbol, Celera Genome (CG) number,
Heidelberg Drosophila Consortium identification number
(HCDID) and general function.
Found at: doi:10.1371/journal.ppat.1000655.s005 (0.50 MB
DOC)
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